NEU-411

· Neuron23 Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NEU-411, covering 2025-02-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease [Phase 2]

See pricing